Rayence Co., Ltd. (KOSDAQ:228850)
South Korea · Delayed Price · Currency is KRW 6,710.00
-90.00 (-1.32%)
At close: Jun 17, 2026
Rayence Market Cap
Rayence has a market cap or net worth of 105.59 billion as of June 17, 2026. Its market cap has decreased by -1.18% in one year.
Market Cap
105.59B
Enterprise Value
-39.84B
Revenue
124.23B
Ranking
n/a
PE Ratio
270.71
Stock Price
6,710.00
Market Cap Chart
Since April 11, 2016, Rayence's market cap has decreased from 382.42B to 105.59B, a decrease of -72.39%. That is a compound annual growth rate of -11.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 105.59B | 29.04% |
| Dec 30, 2025 | 81.83B | -15.45% |
| Dec 30, 2024 | 96.78B | -34.22% |
| Dec 28, 2023 | 147.14B | -15.00% |
| Dec 29, 2022 | 173.10B | -10.20% |
| Dec 30, 2021 | 192.77B | 11.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WITHUS PHARMACEUTICAL Co.,LTD. | 107.99B |
| ONEUL E&M co.,Ltd. | 107.75B |
| Aminologics | 107.68B |
| OPTUS Pharmaceutical | 107.64B |
| RoboRobo | 106.95B |
| BIOBIJOU | 106.51B |
| ActRO | 106.39B |
| Korea Robot Manufacturing | 106.36B |